A Two-Step Approach to Reduced Intensity Bone Marrow Transplant for Patients With Hematological Malignancies
Thomas Jefferson University
Thomas Jefferson University
Incyte Corporation
Eilean Therapeutics
National Cancer Institute (NCI)
National Cancer Institute (NCI)
University of Turin, Italy
Novartis
Merck Sharp & Dohme LLC
M.D. Anderson Cancer Center
Prelude Therapeutics
University of Southern California
Italfarmaco
University Hospital, Brest